Heart Rhythm

Hearts should have normal rhythm to their beats, but when these beats are out of synch, it causes inefficient pumping of blood. Irregular heart arrhythmias occur when the electrical signals that coordinate the heart's beats do not work properly. This can cause beats that are too fast (tachycardia), or too slow (bradycardia). Tachycardias include atrial fibrillation (AFib), supraventricular tachycardia, ventricular fibrillation, and ventricular tachycardia (VT). Bradycardias include sick sinus syndrome and conduction block. Electrophysiology arrhythmia treatments include medications, life style changes, and the EP lab interventions of catheter ablation, and implantable pacemakers or defibrillators.

HRS: Lead management, ablation updates on tap at meeting

Heart Rhythm Society (HRS) will offer new sessions as well as topics that were well received at previous meetings for its 2013 scientific sessions scheduled May 8-11 in Denver.

Electrophysiology devices market worth US$4.4 billion by 2015

Global electrophysiology devices market forecasts to reach at US$4.4 billion by 2015 at a CAGR of 9.7% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.8% driving a market value of US$1.1 billion by 2015.

Find out if your cath/EP lab is paying competitive wages

Cath/EP and interventional lab professionals wondering if their pay is competitive are being offered an objective measuring stick from a new research poll, Phoenix-based Springboard Healthcare announced.

Boston Scientific begins clinical trial to evaluate new pacing system in MRI environment

The first patient in the United States has been implanted with the Boston Scientific Corporation (NYSE: BSX) next generation ImageReady™ MR Conditional pacing system in the SAMURAI clinical trial.

FDA approves first single-lead ICD with atrial sensing

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System. This novel device is a first-in-class implantable cardiac defibrillator (ICD) that utilizes a single lead with atrial sensing capabilities.   

ACC video: Women with AF have similar outcomes to men, but quality of life varies

SAN FRANCISCO—ORBIT-AF is a prospective, longitudinal, observational study that evaluated treatment patterns and the subsequent outcomes of 10,000 patients in the U.S. As part of the analysis, Jonathan P. Piccini, MD, and his colleagues looked at potential gender disparities in the treatment and clinical outcomes of these patients. The results were presented at the American College of Cardiology (ACC) scientific session.

The Networked EP Lab

New for Heart Rhythm 2011, the Networked EP Lab will prepare electrophysiologists for the future of health information technology (HIT). Visitors will discover new processes and technologies to integrate into the EP Lab to optimize patient safety, outcomes and improve procedural management and outcomes.

Texas hospital develops center for treatment of heart rhythm disorders

St. David’s HealthCare, along with Texas Cardiac Arrhythmia, hasdeveloped the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’sMedical Center in Austin.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

 

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup